A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
Public ClinicalTrials.gov record NCT01561053. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the changes in the cognitive, functional, behavioral and global domains based on the different applicable psychometric batteries and scales.
Study identification
- NCT ID
- NCT01561053
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 347 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 55 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 19, 2012 (Actual)
- Primary completion
- Mar 6, 2018 (Actual)
- Completion
- Mar 6, 2018 (Actual)
- Last update posted
- Jul 31, 2019
2012 – 2018
United States locations
- U.S. sites
- 22
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northern California Research | Sacramento | California | 95821 | — |
| Mountain View Clinical Research, Inc | Denver | Colorado | 80209 | — |
| Howard University | Washington D.C. | District of Columbia | 20059 | — |
| Bradenton Research Center, Inc. | Bradenton | Florida | 34205 | — |
| Quantum Laboratories | Deerfield Beach | Florida | 33064 | — |
| Galiz Research, LLC | Hialeah | Florida | 33016 | — |
| Largo Medical Center | Largo | Florida | 33770 | — |
| L&L Research Choices, Inc | Miami | Florida | 33144 | — |
| Allied Biomedical Research Institute | Miami | Florida | 33155 | — |
| Miami Dade Medical Research Institute, LLC | Miami | Florida | 33176 | — |
| Neurology Associates of Osmond Beach | Ormond Beach | Florida | 32174 | — |
| PharmaSeek LLC (DMI Research) | Pinellas Park | Florida | 33782 | — |
| iResearch Atlanta, LLC | Decatur | Georgia | 30030 | — |
| RTR Medical Group | Savannah | Georgia | 31419 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| The NeuroCognitive Institute | Mount Arlington | New Jersey | 08756 | — |
| Mid-Atlantic Geriatric/ARC | Paterson | New Jersey | 08759 | — |
| The Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Neurology Specialists Inc | Dayton | Ohio | 45417 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Roper St. Francis Healthcare | Charleston | South Carolina | 29401 | — |
| Wesley Neurology Clinic | Cordova | Tennessee | 38018 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01561053, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2019 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01561053 live on ClinicalTrials.gov.